Last session

Lantheus Holdings, Inc. (LNTH) on Decifer Markets

Decifer Markets ranks LNTH number 181 of 276 tracked names on durable business quality.

Why it ranks here

  • It keeps about 23 cents of every sales dollar as cash, safer than 87 in 100 companies we measure.
  • It earns about 12% a year on the money put into the business, better than 62 in 100 companies we measure.
  • It costs about 25 times its yearly profit; the middle of its industry is 14. Cheaper than 18 in 100 companies we measure, against their own industries.
  • It makes about 42 cents of gross profit a year on each dollar of assets, more than 75 in 100 companies we measure.
  • Its share count fell about 4.5% over the last year. On not spreading the company over more shares it stands ahead of 89 in 100 companies we measure.
  • Its assets grew about 12% over the last year. On keeping expansion modest it stands ahead of 35 in 100 companies we measure.
  • Its share price rose about 90% over the past year, leaving out the latest month. Stronger than 92 in 100 companies we measure.

The current read

The evidence on LNTH lines up on the supportive side: a live market force supports this name through its theme connection. The independent signals we track are telling the same story.

Themes

  • Genomic Medicine & Precision Diagnostics: The collapsing cost of DNA/RNA sequencing and validation of genomic classifiers is moving clinical practice toward routine molecular diagnostics and companion testing.

Read the full LNTH research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.

Decifer Markets is a media publication. Nothing here is investment advice, a recommendation, or an offer to buy or sell any security.

DisclaimerTermsPrivacyAbout